Featured Stack

Deep Sleep Architecture

GLCurated by Dr. Andrew Huberman

A targeted multi-compound stack designed to decrease sleep latency, extend deep sleep phases, and optimize morning cortisol awakening response.

Adherence Difficulty: Moderate

Stack write-up

Written by Dr. Andrew HubermanSource: user write-up
Primary Intent

Shorten sleep latency while preserving a natural sleep onset curve.

Secondary Intent

Support slower evening arousal and fewer mid-night awakenings.

Not Designed For

Acute insomnia rescue, jet lag, or sedation after stimulant overuse.

Best Used When

The user has a consistent bedtime but struggles to downshift mentally.

Stack Timeline
T-90

Dim environment

Begin light reduction and stop high-friction work.

T-60

Dose magnesium + apigenin + theanine

Take with water away from large meals.

T-30

Low-stimulation wind-down

Reading, breathwork, or quiet conversation only.

T+0

Lights out

Keep wake time consistent the next morning.

Rationale & Mechanics

The transition into restorative sleep relies on a cascade of neurochemical shifts, primarily the attenuation of excitatory neurotransmitters and the up-regulation of inhibitory systems.

This stack layers compounds that act synergistically on these pathways without introducing the tolerance or dependency profile associated with stronger pharmacological interventions.

Magnesium threonate acts as an NMDA target antagonist while actively enhancing synaptic density. Its unique ability to cross the blood-brain barrier makes it relevant for sleep onset rather than simple mineral replacement.

Apigenin, a bioflavonoid, functions as a mild ligand for central benzodiazepine targets, augmenting GABAergic activity. L-theanine promotes alpha-wave generation and reduces sympathetic arousal.

End of stack write-upDatabase analysis begins below

Glass Label Generated Analysis

Component Inferred

Generated from linked component records. This is not evidence that the full stack has been clinically tested.

Intended effects
3
Additional effects
4
Safety domains
5
Coverage gaps
2
Effect Breakdown7 effects
Intended Effects
Effect

Sleep-quality-improvement

Linked Components
Magnesium ThreonateL-Theanine
Estimated Signal
Low
Component Evidence
Not Assessed-Low
Component Evidence Audit

These are component-level records. They do not show that the full stack has been clinically tested.

Magnesium Threonate/compound

May support sleep quality indirectly through magnesium status and nervous-system excitability.

Evidence: lowMagnitude: low1 citations
L-Theanine/compound

Sleep Quality Improvement is indexed as a partial L-Theanine effect from the compound directory seed.

Evidence: not assessedMagnitude: not assessed0 citations
Effect

Sleep-latency-reduction

Linked Components
Apigenin
Estimated Signal
Low
Component Evidence
Low
Component Evidence Audit

These are component-level records. They do not show that the full stack has been clinically tested.

Apigenin/compound

Modeled as a mild sleep-latency support signal through GABAergic and calming-context mechanisms.

Evidence: lowMagnitude: low1 citations
Effect

Anxiolysis

Linked Components
ApigeninL-Theanine
Estimated Signal
Low
Component Evidence
Not Assessed-Low
Component Evidence Audit

These are component-level records. They do not show that the full stack has been clinically tested.

Apigenin/compound

Associated with calming and anxiolytic-like activity in mechanistic and preclinical models.

Evidence: lowMagnitude: low1 citations
L-Theanine/compound

Anxiolysis is indexed as a partial L-Theanine effect from the compound directory seed.

Evidence: not assessedMagnitude: not assessed0 citations
Additional Indexed Effects4 effects
Effect

Cognitive-support

Linked Components
Magnesium Threonate
Estimated Signal
Low To Moderate
Component Evidence
Medium
Component Evidence Audit

These are component-level records. They do not show that the full stack has been clinically tested.

Magnesium Threonate/compound

Linked to cognitive support through brain magnesium and synaptic plasticity models.

Evidence: mediumMagnitude: low to moderate2 citations
Effect

Neuroplasticity-support

Linked Components
Magnesium Threonate
Estimated Signal
Moderate
Component Evidence
Medium
Component Evidence Audit

These are component-level records. They do not show that the full stack has been clinically tested.

Magnesium Threonate/compound

Associated with synaptic density and plasticity markers in preclinical and translational models.

Evidence: mediumMagnitude: moderate1 citations
Effect

Nad-maintenance

Linked Components
Apigenin
Estimated Signal
Uncertain
Component Evidence
Low
Component Evidence Audit

These are component-level records. They do not show that the full stack has been clinically tested.

Apigenin/compound

Linked to CD38/NAD+ maintenance in mechanistic seed data.

Evidence: lowMagnitude: uncertain1 citations
Effect

Cognitive-enhancement

Linked Components
L-Theanine
Estimated Signal
Not Assessed
Component Evidence
Not Assessed
Component Evidence Audit

These are component-level records. They do not show that the full stack has been clinically tested.

L-Theanine/compound

Cognitive Enhancement is indexed as a partial L-Theanine effect from the compound directory seed.

Evidence: not assessedMagnitude: not assessed0 citations
Safety / Caution Layer5 domains
Safety Domains

Sedation / CNS depression

High
3 records / 3 citations
Apigenin
AvoidInteractionMonitoring NoteAdverse EffectAdditive EffectTiming SensitiveMonitoring Burden
Component Safety Records
Apigenin/High
Sedatives and alcohol
InteractionAvoid1 citationsAdditive Effect
Apigenin/Medium
Sedation
Monitoring NoteMonitor1 citationsTiming SensitiveMonitoring Burden
Apigenin/Medium
Sedation / drowsiness
Adverse EffectUse Caution1 citations

Renal clearance / impaired elimination

Medium
1 records / 1 citations
Magnesium Threonate
Use CautionCaution Context
Component Safety Records
Magnesium Threonate/Medium
Renal impairment
Caution ContextUse Caution1 citations

Electrolytes / duplicate mineral exposure

Medium
1 records / 1 citations
Magnesium Threonate
MonitorDuplicate ExposureDuplicate Exposure
Component Safety Records
Magnesium Threonate/Medium
Duplicate magnesium exposure
Duplicate ExposureMonitor1 citationsDuplicate Exposure

Immune / allergy sensitivity

Medium
1 records / 1 citations
Apigenin
Use CautionCaution Context
Component Safety Records
Apigenin/Medium
Ragweed / Asteraceae allergy context
Caution ContextUse Caution1 citations

GI tolerance

Low
2 records / 2 citations
Magnesium Threonate
Use CautionAdverse EffectMonitoring Note
Component Safety Records
Magnesium Threonate/Low
GI discomfort
Adverse EffectUse Caution1 citations
Magnesium Threonate/Low
GI tolerance
Monitoring NoteMonitor1 citations
Coverage Gaps
unprofiled

L-Theanine

No indexed safety profile for this linked item.

unlinked

Blue Lotus Extract

Not linked to a Glass Label entity record.

Component Safety Audit

Sedation / CNS depression

3 records
Apigenin/High

Sedatives and alcohol

Cns DepressionInteractionAvoid1 citations
Apigenin/Medium

Sedation

Cns DepressionMonitoring NoteMonitor1 citations
Apigenin/Medium

Sedation / drowsiness

Cns DepressionAdverse EffectUse Caution1 citations

Renal clearance / impaired elimination

1 records
Magnesium Threonate/Medium

Renal impairment

Renal ClearanceCaution ContextUse Caution1 citations

Electrolytes / duplicate mineral exposure

1 records
Magnesium Threonate/Medium

Duplicate magnesium exposure

ElectrolytesDuplicate ExposureMonitor1 citations

Immune / allergy sensitivity

1 records
Apigenin/Medium

Ragweed / Asteraceae allergy context

Immune AllergyCaution ContextUse Caution1 citations

GI tolerance

2 records
Magnesium Threonate/Low

GI discomfort

Gi ToleranceAdverse EffectUse Caution1 citations
Magnesium Threonate/Low

GI tolerance

Gi ToleranceMonitoring NoteMonitor1 citations
Evidence Sources12 sources

Sources are grouped by component-effect and safety records. Stack source groups are inferred from linked components, not from studies of the full stack.

Sources for Intended Effects
Sleep2 sources
Lower evening arousal1 source
Sources for Other Indexed Effects
Cognitive-support2 sources
Neuroplasticity-support1 source
Nad-maintenance1 source
Sources for Safety
Sedation / CNS depression1 source
Immune / allergy sensitivity1 source
Electrolytes / duplicate mineral exposure1 source
Renal clearance / impaired elimination1 source
GI tolerance1 source
Version History
Related Stacks
GL
Glass Label Editorial
Updated Apr 2026

Minimal Sleep Stack

A lower-cost two-compound version for users testing sensitivity before adopting the full stack.

92 forks
1.1k saves
MA
M. Arlen
Updated Mar 2026

Travel Sleep Reset

A timezone-shift stack focused on light timing, melatonin discipline, and reducing first-night hotel insomnia.

63 forks
740 saves
RS
Rhea Somatics
Updated May 2026

Stress Recovery Evening

A broader wind-down stack for users with elevated training load, late work stress, or high sympathetic tone.

128 forks
1.9k saves
Comments & Field Reports

Comments and field reports

User discussion can handle substitutions, tolerance, modified timings, and real-world adherence.

ER
Eli R.
Forked v1.2 · 2 days ago

I removed the theanine on nights where I already felt calm. The magnesium/apigenin pairing still carried most of the benefit for me.

NK
Nadia K.
Saved · 1 week ago

The stack timeline is the useful part. Taking everything at T-60 was less important than actually dimming lights and stopping work earlier.

JM
Jonas M.
Commented · 3 weeks ago

Would like to see a lower-cost version with glycinate. Threonate is the expensive part if this becomes a nightly stack.

GL
Glass Label Reader
Drafting a field report
Comment Draft

This stack is user-facing educational content and is not medical advice. Supplements may interact with medications, medical conditions, sleep disorders, alcohol, or sedatives. Users should consult a qualified clinician before applying stacks to clinical conditions.